Chemomab Therapeutics Ltd (CMMB)
0.87
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.7903
-0.08
(-9.16%)
After-Hours: 20:00
Chemomab Therapeutics Total Assets (Quarterly): 18.01M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 18.01M |
| June 30, 2023 | 28.85M |
| March 31, 2023 | 35.01M |
| December 31, 2022 | 43.06M |
| September 30, 2022 | 50.22M |
| June 30, 2022 | 56.38M |
| Date | Value |
|---|---|
| March 31, 2022 | 60.96M |
| December 31, 2021 | 64.35M |
| September 30, 2021 | 67.44M |
| June 30, 2021 | 70.52M |
| March 31, 2021 | 60.12M |
| December 31, 2020 | 12.48M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
12.48M
Minimum
Dec 2020
70.52M
Maximum
Jun 2021
47.28M
Average
53.30M
Median
Total Assets (Quarterly) Benchmarks
| Compugen Ltd | 121.33M |
| Pluri Inc | 36.39M |
| BioLine Rx Ltd | 63.92M |
| Can Fite Biofarma Ltd | 9.989M |
| BiomX Inc | 25.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.678M |
| Shareholders Equity (Quarterly) | 13.33M |